As the binding affinity between SARS-CoV-2S protein and ACE2 dictates transmissibility and disease severity, the presence of two cell lines and subsequently two ACE2 variants in women may contribute to the sex-based differences observed in COVID-19 patients. This evidence concerns the gene ACE2 and COVID-19.